Neovasc (NVCN) Reports Q4 Loss of $0.14

Go back to Neovasc (NVCN) Reports Q4 Loss of $0.14

Northland Capital Markets Starts Neovasc (NVCN) at Outperform; Seen as Strong Takeout Candidate

March 31, 2015 7:19 AM EDT

Northland Capital Markets initiates coverage on Neovasc (NASDAQ: NVCN) with a Outperform rating and a price target of $12.00.

Analyst Suraj Kalia commented, "We are initiating coverage of Neovasc with an Outperform and $12 price target. Neovasc is an early-stage company developing its transcatheter mitral... More